Novavax Major Shareholder Calls For Sale Of Company To Larger Pharma Entity

2025-10-14 09:00:51

(MENAFN- AsiaNet News)

Novavax (NVAX) shares traded 1% higher in the pre-market session on Tuesday after its second-largest shareholder, Shah Capital, called for the sale of the company, citing persistent underperformance.

Shah Capital currently owns 11.8 million shares or 7.2% of Novavax. The firm said in a letter to the Novavax board of directors that since March 2023, its concerns have accelerated with“Nuvoxovid's rollout slipups including this fall, timid/ineffective marketing, extremely poor capital market actions, and tremendous lack of accountability.”

“Novavax's IP and scientific capabilities will have far greater upside potential in the hands of large capable pharma entity,” Shah Capital said, while recommending an immediate formal strategic review for the sale of the company.

Get updates to this developing story <directly on Stocktwits.

MENAFN14102025007385015968ID1110193942

Legal Disclaimer:
MENAFN provides the information “as is” without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the provider above.